On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K-Vax vaccine candidate against Klebsiella pneumoniae, which is responsible for o...
Read moreLa Fundación Niemann-Pick España ha entregado al IDIBELL y el Hospital de Bellvitge un cheque por valor de 104.884 euros que se destinarán íntegramente a la continuación de un estudio para determ...
Read moreLaminar Pharma es una empresa biotecnológica española que está desarrollando su principal compuesto LAM561, un derivado sintético del ácido oleico que puede ingerirse por vía oral. Este fármaco...
Read moreGuadalupe Sabio, Felipe Cortés y Rafael Fernández dirigen respectivamente cada uno de los tres proyectos de investigación del Centro de Investigaciones Oncológicas (CNIO) seleccionados en convocat...
Read moreIRB Barcelona receives funding for two research projects, headed by Drs. Eduard Batlle and Roger Gomis, in the CaixaResearch call.
Read moreThe Centre for Genomic Regulation (CRG) has received two grants in the CaixaResearch call for Health Research 2024. Dr. Pia Cosma and Dr. Luis Serrano have received around one million euros each to...
Read moreBiorce, a Barcelona based TechBio company dedicated to transforming clinical trials through artificial intelligence, has announced the successful completion of a €3.5 million funding round. The inve...
Read moreUn trabajo liderado desde el Instituto de Biomedicina de Valencia (CSIC) describe en ratones que la ausencia de un gen altera el modo en el que las células obtienen energía
Read moreThe IRB Barcelona spin-off Gate2Brain has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for ...
Read moreIn total, it will promote 26 research projects in sexual and reproductive health led by 52 research teams
Read moreEl LOLA Project (Liquid Biopsy, Lung and Colon Cancer in Andalusia) begins its mission to transform the diagnosis and treatment of lung and colon cancer in the Andalusian Public Health System by integ...
Read moreAdcendo, a biotech company focused on the development of first-in-class ADCs for the treatment of cancers with a high unmet medical need, today announced the successful closing of an oversubscribed $1...
Read more